Flexible Fiber Optic vs Digital Ureteroscopy and Enhanced vs Unenhanced imaging for Diagnostic and Treatment of Upper Tract Urothelial Carcinoma: Results from the Clinical Research Office of the Endourology Society (CROES)-UTUC Registry

Objectives: To compare the oncological outcomes of patients with upper tract urothelial carcinoma (UTUC) undergoing kidney-sparing surgery (KSS) with fiber-optic (FO) vs digital (D) ureteroscopy (URS). To evaluate the oncological impact of image enhance technologies such as narrow-band imaging (NBI)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BJU international 2021-05
Hauptverfasser: Soria, Francesco, Laguna, M Pilar, Roupret, Morgan, Garcia-Marchinena, Patricio, Sebastián Gonzalez, Mariano, Habuchi, Tomonori, Erkan, Erkan, Ng, Anthony, Gontero, Paolo, de La Rosette, Jean
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives: To compare the oncological outcomes of patients with upper tract urothelial carcinoma (UTUC) undergoing kidney-sparing surgery (KSS) with fiber-optic (FO) vs digital (D) ureteroscopy (URS). To evaluate the oncological impact of image enhance technologies such as narrow-band imaging (NBI) and Image 1S in patients with UTUC.Materials and methods: The CROES-UTUC registry is an international, multicenter, cohort study prospectively collecting data on patients with UTUC. Patients undergoing flexible FO or D-URS for diagnostic or diagnostic and treatment purposes have been included. Differences between groups in terms of overall survival (OS) and disease-free survival (DFS) have been evaluated.Results: The CROES registry included 2380 patients from 101 centers and 37 countries, of whom 401 patients underwent URS (FO-URS:186 and D-URS:215). FO-URS were performed more frequently for diagnostic purposes while D-URS when a combined diagnostic and treatment strategy was planned. Intraoperative and postoperative complications did not differ between groups. 5-years OS and DFS rates were 91.5% and 66.4% respectively. Mean OS was 42 months for patients receiving FO-URS and 39 months for those undergoing D-URS (p=0.9); mean DFS was 28 months in the FO group and 21 months in the D group (p
ISSN:1464-4096
1464-410X
DOI:10.1111/bju.15494